glp 1 trials GLP-1 receptor agonists and cardiovascular outcome trials: An update New Biweekly GLP-1 Shot Lowers

Schultz is a great comic

The reason timing flexibility exists comes down to pharmacokinetics

For partial tears and chronic soft tissue injuries, the wolverine protocol can produce recovery outcomes that make surgery unnecessary

doi: 10.3389/fphar.2021.622841 84 ChenLWangLAoWChenYLiSHuangZet al

Potential muscle-related benefits: Increased appetite (helpful in calorie-surplus phases) Elevated growth hormone Possible preservation of lean mass In a two-year randomized, placebo-controlled trial of the oral ghrelin mimetic MK-677 in older adults, daily dosing significantly increased pulsatile growth hormone and IGF-1 levels to those of younger adults and increased fat-free mass versus placebo, suggesting enhanced protein-accruing pathways that could help preserve lean body mass

WADA resource University of Glasgow